IBX vs IDT

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IBX

IMAGIONBIO FPO [IBX]

44LOW

IDT

IDT AUST FPO [IDT]

43LOW

Score Breakdown

IBX IDT
Technical
61
53
Catalyst
50
50
Sentiment
50
50
Fundamental
11
66
Momentum
62
27
Risk Gate
37
38

Key Metrics

IBX Metric IDT
$10.3MMarket Cap$19.2M
2.0MAvg Volume (20d)92K
N/AShort InterestN/A
$0.05552-Week High$0.115
$0.01152-Week Low$0.041
+22.2%Daily Change+0.0%
$0.022Entry Price$0.045
N/AROE-26.1%
N/AProfit Margin-32.3%

Active Signals

IBX Signals

●MACD just crossed bullish — momentum is shifting to the upside
●Above-average volume (1.8x) on a green day — buyers stepping up
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●On a tear — up 15.8% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●4C filed 2026-01-28
●Very high P/S ratio (141.1x)

IDT Signals

●MACD just crossed bullish — momentum is shifting to the upside
●Volume surging at 2.5x normal while price falls — heavy selling pressure
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.0x)
●Revenue declining (-7%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (5% of range)

Ask Scout AI to compare IBX and IDT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IBX Full Analysis → IDT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).